ReviewCurrent opinion in infectious diseases2018
Scaling up HIV self-testing in sub-Saharan Africa: a review of technology, policy and evidence.
Review in Current opinion in infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
98 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Acceptability and use of HIV self-testing among young people in sub-Saharan Africa: a mixed methods systematic review.BMC primary care · 2024Pooled it
- Consistent condom utilization among sexually active HIV positive individuals in Sub-Saharan Africa: systematic review and meta-analysis.Scientific reports · 2024Pooled it
- Trial
- Effect of index HIV self-testing for sexual partners of clients enrolled in antiretroviral therapy (ART) programs in Malawi: A randomized controlled trial.PLoS medicine · 2023Trial
- Barriers and facilitators to facility HIV self-testing in outpatient settings in Malawi: a qualitative study.BMC public health · 2021Trial
- Traditional healer-delivered point-of-care HIV testing versus referral to clinical facilities for adults of unknown serostatus in rural Uganda: a mixed-methods, cluster-randomised trial.The Lancet. Global health · 2021Trial
- Trial
- Economic evaluation of facility-based HIV self-testing among adult outpatients in Malawi.Journal of the International AIDS Society · 2020Trial
- Social response to the delivery of HIV self-testing in households: experiences from four Zambian HPTN 071 (PopART) urban communities.AIDS research and therapy · 2020Trial
- What happens after HIV self-testing? Results from a longitudinal cohort of Chinese men who have sex with men.BMC infectious diseases · 2019Trial
- Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.Journal of acquired immune deficiency syndromes (1999) · 2018Trial
- Article
- Trends in HIV self-testing uptake in Africa: A modeling study of population-based surveys and HIV testing program data.PLoS medicine · 2026Article
- Peer perspectives on assisted partner notification for HIV and syphilis testing among gay, bisexual, and other men who have sex with men in Uganda: a qualitative study.Discover public health · 2026Article
- Article
- Application of Machine Learning and Emerging Health Technologies in the Uptake of HIV Testing: Bibliometric Analysis of Studies Published From 2000 to 2024.Interactive journal of medical research · 2025Article
- Article
- Understanding the acceptability of COVID-19 antigen rapid diagnostic tests: A multi-country qualitative study.PLOS global public health · 2025Article
- Evaluating the effectiveness of oral HIV self testing according to distribution models in Cameroon.Scientific reports · 2024Article
- HIV Self-Testing: A Discussion on the Benefits, Limitations, and Implications for Public Health with a Focus on Poland.Diagnostics (Basel, Switzerland) · 2024Review
38 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewHIV self-testing (HIVST) can provide complementary coverage to existing HIV testing services and improve knowledge of status among HIV-infected individuals. This review summarizes the current technology, policy and evidence landscape in sub-Saharan Africa and priorities within a rapidly evolving field. RECENT
findingsHIVST is moving towards scaled implementation, with the release of WHO guidelines, WHO prequalification of the first HIVST product, price reductions of HIVST products and a growing product pipeline. Multicountry evidence from southern and eastern Africa confirms high feasibility, acceptability and accuracy across many delivery models and populations, with minimal harms. Evidence on the effectiveness of HIVST on increased testing coverage is strong, while evidence on demand generation for follow-on HIV prevention and treatment services and cost-effective delivery is emerging. Despite these developments, HIVST delivery remains limited outside of pilot implementation. SUMMARY: Important technology gaps include increasing availability of more sensitive HIVST products in low and middle-income countries. Regulatory and postmarket surveillance systems for HIVST also require further development. Randomized trials evaluating the effectiveness and cost-effectiveness under multiple distribution models, including unrestricted delivery and with a focus on linkage to HIV prevention and treatment, remain priorities. Diversification of studies from west and central Africa and around blood-based products should be addressed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.